The rising popularity in GLP-1 agonists for diabetes has led to a debate about delivery methods : skin-applied devices versus tablets . Typically, GLP-1 therapies were solely available in pill form, but https://kathrynnuim800888.kylieblog.com/41479188/glp-1-transdermal-delivery-systems-vs-tablets-which-right-for-individuals